| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-009673 |
| cik | 1584831 |
| name | OXBRIDGE RE HOLDINGS LTD |
| sic | 6331 |
| countryba | KY |
| stprba | |
| cityba | GEORGETOWN |
| zipba | KY1-9006 |
| bas1 | SUITE 201, 42 EDWARD STREET |
| bas2 | P.O. BOX 469 |
| baph | 345-749-7570 |
| countryma | KY |
| stprma | |
| cityma | GEORGETOWN |
| zipma | KY1-9006 |
| mas1 | SUITE 201, 42 EDWARD STREET |
| mas2 | P.O. BOX 469 |
| countryinc | KY |
| stprinc | |
| ein | 981150254 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250512 |
| accepted | 2025-05-12 16:06:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009673 | 20250331 | Cash And Cash Equivalents At Carrying Value | 4963000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Accounts Payable And Other Accrued Liabilities | 432000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Assets | 5330000.0000 | USD | 0 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 9597000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Deferred Policy Acquisition Costs | 44000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Depreciation And Amortization | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Depreciation And Amortization | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20240331 | Foreign Reinsurance Transactions Expense Additions To Underwriting Balances | 28000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Reinsurance Agreement; | ||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Deferred Policy Acquisition Costs | -61000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Prepaid Offering Costs | USD | 1 | 0001641172-25-009673 | ||||
| 0001641172-25-009673 | 20250331 | Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | 14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009673 | 20240331 | Net Investment Income | 62000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Investment Income | 79000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Prepaid Expense And Other Assets | 160000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Proceeds From Issuance Of Common Stock | 448858.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market; | ||
| 0001641172-25-009673 | 20240331 | Proceeds From Sale And Maturity Of Other Investments | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20240331 | Proceeds From Sale Of Equity Securities Fv Ni | 307000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Property Plant And Equipment Net | 1000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Reclassification To Mezzanine Equity | USD | 1 | 0001641172-25-009673 | ||||
| 0001641172-25-009673 | 20241231 | Restricted Cash And Cash Equivalents | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; | |||
| 0001641172-25-009673 | 20240331 | Revenues | -125000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Revenues | 488000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20250331 | Revenues | 536000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 37335000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009673 | 20230630 | Stock Issued During Period Shares New Issues | 244776.0000 | shares | 0 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Shares Share Based Compensation | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009673 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Common Stock Shares Outstanding | 6379002.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Common Stock Value | 6000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Deferred Policy Acquisition Costs | 18000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Reinsurance Agreement; | ||
| 0001641172-25-009673 | 20250331 | Equity Securities Fv Ni | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; | |||
| 0001641172-25-009673 | 20250331 | Foreign Reinsurance Transactions Expense Additions To Underwriting Balances | 65000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | 66000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Liabilities | 1069000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Cash Provided By Used In Financing Activities | 3369000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Net Cash Provided By Used In Operating Activities | -276000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss | -139000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009673 | 20250331 | Notes Payable | 118000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Other Investments | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Jet A I Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Proceeds From Issuance Of Common Stock | 3122000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Proceeds From Issuance Of Debt | 247000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Restricted Cash And Cash Equivalents | 4634000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001641172-25-009673 | 20250331 | Restricted Cash And Cash Equivalents | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | |||
| 0001641172-25-009673 | 20241231 | Shares Outstanding | 6379002.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20241231 | Stockholders Equity | 2470000.0000 | USD | 0 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 4499000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -30163000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009673 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 176000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001641172-25-009673 | 20230630 | Stock Issued During Period Shares New Issues | 229766.0000 | shares | 0 | us-gaap/2024 | Legal Entity= Surance Plus Inc; Title Of Individual= Investors And Non U S Persons; Type Of Arrangement= Subscription Agreements; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 83162.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 72000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 72000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009673 | 20241231 | Unearned Premiums | 991000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Unrealized Gain Loss On Investments | -688000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 6899062.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Earnings Per Share Diluted | -0.1500 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Earnings Per Share Diluted | -0.0200 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Equity Securities Fv Ni | 116000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | General And Administrative Expense | 505000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Income Attributable To Noteholders | -247000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Operating Lease Liability | -26000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 27000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Prepaid Offering Costs | 12000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20240331 | Loss Income Before Income Attributable To Tokenholders And Noncontrolling Interests | -673000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20240331 | Net Cash Provided By Used In Investing Activities | 448000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss | 24000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20250331 | Net Income Loss Attributable To Noncontrolling Interest | 14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Notes Payable | 118000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Operating Lease Right Of Use Asset | 122000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Other Investments | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20241231 | Restricted Cash And Cash Equivalents | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | |||
| 0001641172-25-009673 | 20250331 | Retained Earnings Accumulated Deficit | -30302000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Revenues | 488000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; Product Or Service= Underwriting Related Income; | ||
| 0001641172-25-009673 | 20250331 | Revenues | 692000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5332000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 34105000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009673 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 162000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001641172-25-009673 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -30302000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009673 | 20250228 | Stock Issued During Period Shares New Issues | 705884.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Offering; Type Of Arrangement= Securities Purchase Agreement; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009673 | 20250331 | Unrealized Gain Loss On Investments | -20000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 567000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Deferred Policy Acquisition Costs | 109000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Equity Securities Fv Ni | 113000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001641172-25-009673 | 20250331 | Equity Securities Fv Ni | 116000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001641172-25-009673 | 20241231 | Equity Securities Fv Ni Cost | 1532000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Foreign Reinsurance Transactions Expense Additions To Underwriting Balances | 60000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Income Attributable To Noteholders | -232000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -905000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -125000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Operating Right Of Use Asset | USD | 1 | 0001641172-25-009673 | ||||
| 0001641172-25-009673 | 20240331 | Interest And Gain On Redemption Of Loan | 41000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20250331 | Interest And Gain On Redemption Of Loan Receivable | USD | 1 | 0001641172-25-009673 | ||||
| 0001641172-25-009673 | 20241231 | Liabilities And Stockholders Equity | 7465000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Cash Provided By Used In Investing Activities | 63000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Net Income Loss | -905000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009673 | 20241231 | Other Investments | 48000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001641172-25-009673 | 20241231 | Other Investments | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | |||
| 0001641172-25-009673 | 20250331 | Premiums Earned Net | 595000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Proceeds From Issuance Of Debt | 395000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Proceeds From Sale Of Equity Securities Fv Ni | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20250331 | Property Plant And Equipment Net | 1000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Revenues | 529000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; Product Or Service= Underwriting Related Income; | ||
| 0001641172-25-009673 | 20250331 | Share Based Compensation | 108000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Shares Outstanding | 6006661.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -27414000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009673 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Shares New Issues | 177159.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 136427.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009673 | 20250331 | Unearned Premiums | 397000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 6005162.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Cash And Cash Equivalents At Carrying Value | 2135000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Unearned Premiums | -549000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Accounts Payable And Other Accrued Liabilities | 366000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Assets | 7465000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Assets | 10263000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Benefits Losses And Expenses | 548000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 5893000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 3704000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Common Stock Shares Issued | 6379002.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Common Stock Shares Issued | 7442922.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Common Stock Value | 6000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Equity Securities Fv Ni Gain Loss | -89000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | General And Administrative Expense | 488000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Deferred Policy Acquisition Costs | -65000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Premiums Receivable | -488000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Interest And Gain On Redemption Of Loan Receivable | 41000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20241231 | Liabilities | 1623000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Minority Interest | 162000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Cash Provided By Used In Operating Activities | 272000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009673 | 20241231 | Operating Lease Right Of Use Asset | 148000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Premiums Receivable At Carrying Value | 1059000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Proceeds From Redemption Of Loan Receivable | USD | 1 | 0001641172-25-009673 | ||||
| 0001641172-25-009673 | 20240331 | Realized Investment Gains Losses | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20241231 | Restricted Cash And Cash Equivalents | 3758000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001641172-25-009673 | 20240331 | Revenues | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; Product Or Service= Surance Plus Management Fee Income; | |||
| 0001641172-25-009673 | 20231231 | Shares Outstanding | 5870234.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20241231 | Stockholders Equity | 3948000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 4110000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Shares New Issues | 1000000.0000 | shares | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20250331 | Additional Paid In Capital Common Stock | 37335000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Assets | 4794000.0000 | USD | 0 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20240331 | Earnings Per Share Basic | -0.1500 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Earnings Per Share Basic | -0.0200 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Equity Securities Fv Ni | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | -142000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Premiums Receivable | -836000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Net Income Loss | 31000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20250331 | Net Income Loss | -139000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009673 | 20240331 | Net Income Loss Attributable To Noncontrolling Interest | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20241231 | Operating Lease Liability | 148000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Other Investments | 48000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Other Investments | 63000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Jet A I Stock; | ||
| 0001641172-25-009673 | 20240331 | Premiums Earned Net | 549000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Premiums Receivable At Carrying Value | 223000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Reinsurance Agreement; | ||
| 0001641172-25-009673 | 20250331 | Realized Investment Gains Losses | 35000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Restricted Cash And Cash Equivalents | 4634000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Retained Earnings Accumulated Deficit | -30163000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Rightofuse Lease Asset Obtained In Exchange For Operating Lease Liabilities | 148000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20250331 | Rightofuse Lease Asset Obtained In Exchange For Operating Lease Liabilities | USD | 1 | 0001641172-25-009673 | ||||
| 0001641172-25-009673 | 20240331 | Share Based Compensation | 72000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Stockholders Equity | 7039000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 32740000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009673 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -28319000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009673 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 7215000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009673 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 6005162.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 6899062.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Common Stock Shares Outstanding | 7442922.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Equity Securities Fv Ni | 113000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Equity Securities Fv Ni Cost | 1532000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Equity Securities Fv Ni Gain Loss | 3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Operating Right Of Use Asset | -26000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Premiums Receivable | 0.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Reinsurance Agreement; | ||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 66000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Increase Decrease In Unearned Premiums | -594000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Liabilities And Stockholders Equity | 10263000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Loss Income Before Income Attributable To Tokenholders And Noncontrolling Interests | 122000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20250331 | Minority Interest | 176000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Net Income Loss | -905000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20250331 | Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | 14000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001641172-25-009673 | 20241231 | Other Investments | 48000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Jet A I Common Stock; | ||
| 0001641172-25-009673 | 20240331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20241231 | Restricted Cash And Cash Equivalents | 3758000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Shares Outstanding | 7442922.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20250331 | Stockholders Equity | 2494000.0000 | USD | 0 | us-gaap/2024 | Legal Entity= Surance Plus Inc; | SurancePlusInc | |
| 0001641172-25-009673 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20240630 | Stock Issued During Period Shares New Issues | 287705.0000 | shares | 0 | us-gaap/2024 | Legal Entity= Surance Plus Inc; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001641172-25-009673 | 20250228 | Stock Issued During Period Value New Issues | 3000000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Offering; Type Of Arrangement= Securities Purchase Agreement; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value New Issues | 3122000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value New Issues | 3122000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 108000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | 1979000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Additional Paid In Capital Common Stock | 34105000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Benefits Losses And Expenses | 570000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 3745000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 4312000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Equity Securities Fv Ni | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | |||
| 0001641172-25-009673 | 20241231 | Equity Securities Fv Ni | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; | |||
| 0001641172-25-009673 | 20240331 | Increase Decrease In Operating Lease Liability | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20250331 | Interest And Gain On Redemption Of Loan | USD | 1 | 0001641172-25-009673 | ||||
| 0001641172-25-009673 | 20240331 | Net Cash Provided By Used In Financing Activities | 395000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009673 | 20250331 | Operating Lease Liability | 122000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Other Investments | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; | |||
| 0001641172-25-009673 | 20250331 | Premiums Receivable At Carrying Value | 223000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Prepaid Expense And Other Assets | 94000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Proceeds From Redemption Of Loan Receivable | 141000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20250331 | Proceeds From Sale And Maturity Of Other Investments | 63000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20250331 | Reclassification To Mezzanine Equity | 1732000.0000 | USD | 1 | 0001641172-25-009673 | |||
| 0001641172-25-009673 | 20250331 | Restricted Cash And Cash Equivalents | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; | |||
| 0001641172-25-009673 | 20250331 | Revenues | 7000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Surance Plus Inc; Product Or Service= Surance Plus Management Fee Income; | ||
| 0001641172-25-009673 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 32812000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Shares New Issues | 803599.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009673 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 108000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 1732000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009673 | 20240331 | Unearned Premiums | 167000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Reinsurance Agreement; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Prepaid Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Deferred Policy Acquisition Costs | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Policy Acquisition Cost | Amount of deferred policy acquisition cost capitalized on contract remaining in force. |
| Equity Securities Fv Ni | us-gaap/2024 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Current | Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Increase Decrease In Premiums Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Premiums Receivable | The change in the premium receivable balance on the balance sheet. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. |
| Realized Investment Gains Losses | us-gaap/2024 | 0 | 0 | monetary | D | C | Realized Investment Gains (Losses) | Amount of realized gain (loss) on investment. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Stock Issued During Period Value Share Based Compensation Gross | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture | Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Increase Decrease In Operating Right Of Use Asset | 0001641172-25-009673 | 1 | 0 | monetary | D | C | IncreaseDecreaseInOperatingRightOfUseAsset | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Equity Securities Fv Ni Cost | us-gaap/2024 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Cost | Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value. |
| Foreign Reinsurance Transactions Expense Additions To Underwriting Balances | us-gaap/2024 | 0 | 0 | monetary | D | D | Foreign Reinsurance Transactions, Expense Additions to Underwriting Balances | The amount of expenses on insured risks paid or due and owing to the ceding entity, recorded as additions to net premiums written minus net losses paid minus the sum of loss adjustment expenses and underwriting costs and expenses on insurance ceded to companies outside the United States. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Premiums Receivable At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Premiums Receivable, Net | The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts. |
| Unearned Premiums | us-gaap/2024 | 0 | 0 | monetary | I | C | Unearned Premiums | Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date. |
| Benefits Losses And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Benefits, Losses and Expenses | The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. |
| Income Attributable To Noteholders | 0001641172-25-009673 | 1 | 0 | monetary | D | C | Income attributable to tokenholders | |
| Reclassification To Mezzanine Equity | 0001641172-25-009673 | 1 | 0 | monetary | D | C | EpsilonCat Re / DeltaCat Re Tokenholders to Mezzanine Equity | |
| Accounts Payable And Other Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Other Accrued Liabilities | Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other. |
| Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability | Present value of lessee's discounted obligation for lease payments from operating lease. |
| Proceeds From Issuance Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Debt | The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Unrealized Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss) on Investments | Amount of unrealized gain (loss) on investment. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Premiums Earned Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Premiums Earned, Net | Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other. |
| Increase Decrease In Prepaid Offering Costs | 0001641172-25-009673 | 1 | 0 | monetary | D | C | IncreaseDecreaseInPrepaidOfferingCosts | Increase decrease in prepaid offering costs. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable | Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. |
| Proceeds From Sale Of Equity Securities Fv Ni | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Equity Securities, FV-NI | Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity. |
| Interest And Gain On Redemption Of Loan Receivable | 0001641172-25-009673 | 1 | 0 | monetary | D | C | InterestAndGainOnRedemptionOfLoanReceivable | Interest and gain on redemption of loan receivable. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Increase Decrease In Unearned Premiums | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Unearned Premiums | Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income. |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Equity Securities Fv Ni Gain Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Equity Securities, FV-NI, Gain (Loss) | Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | Portion of net income (loss) attributable to nonredeemable noncontrolling interest. |
| Proceeds From Sale And Maturity Of Other Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Other Investments | The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Gross | Aggregate value of stock related to Restricted Stock Awards issued during the period. |
| Loss Income Before Income Attributable To Tokenholders And Noncontrolling Interests | 0001641172-25-009673 | 1 | 0 | monetary | D | C | LossIncomeBeforeIncomeAttributableToTokenholdersAndNoncontrollingInterests | Loss income before income attributable to tokenholders and noncontrolling interests. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Net Investment Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Investment Income | Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. |
| Other Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Investments | Amount of investments classified as other. |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Restricted Cash And Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash and Cash Equivalents | Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Interest And Gain On Redemption Of Loan | 0001641172-25-009673 | 1 | 0 | monetary | D | C | Interest and gain on redemption of loan receivable | Interest and gain on redemption of loan. |
| Rightofuse Lease Asset Obtained In Exchange For Operating Lease Liabilities | 0001641172-25-009673 | 1 | 0 | monetary | D | D | Right-of-use lease asset obtained in exchange for operating lease liabilities | |
| Increase Decrease In Deferred Policy Acquisition Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Deferred Policy Acquisition Costs | The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers. |
| Minority Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Proceeds From Redemption Of Loan Receivable | 0001641172-25-009673 | 1 | 0 | monetary | D | D | Proceeds (funding) of loan receivable | Proceeds from redemption of loan receivable. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009673 | 2 | 3 | BS | 0 | H | Equity Securities Fv Ni | us-gaap/2024 | Equity securities, at fair value (cost: $1,532 and $1,532) | 0 |
| 0001641172-25-009673 | 2 | 4 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-009673 | 2 | 5 | BS | 0 | H | Restricted Cash And Cash Equivalents | us-gaap/2024 | Restricted cash and cash equivalents | 0 |
| 0001641172-25-009673 | 2 | 6 | BS | 0 | H | Premiums Receivable At Carrying Value | us-gaap/2024 | Premiums receivable | 0 |
| 0001641172-25-009673 | 2 | 7 | BS | 0 | H | Other Investments | us-gaap/2024 | Other Investments | 0 |
| 0001641172-25-009673 | 2 | 8 | BS | 0 | H | Deferred Policy Acquisition Costs | us-gaap/2024 | Deferred policy acquisition costs | 0 |
| 0001641172-25-009673 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001641172-25-009673 | 2 | 10 | BS | 0 | H | Prepaid Expense And Other Assets | us-gaap/2024 | Prepayment and other assets | 0 |
| 0001641172-25-009673 | 2 | 11 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001641172-25-009673 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001641172-25-009673 | 2 | 14 | BS | 0 | H | Notes Payable | us-gaap/2024 | Notes payable to noteholders | 0 |
| 0001641172-25-009673 | 2 | 15 | BS | 0 | H | Unearned Premiums | us-gaap/2024 | Unearned premiums reserve | 0 |
| 0001641172-25-009673 | 2 | 16 | BS | 0 | H | Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
| 0001641172-25-009673 | 2 | 17 | BS | 0 | H | Accounts Payable And Other Accrued Liabilities | us-gaap/2024 | Accounts payable and other liabilities | 0 |
| 0001641172-25-009673 | 2 | 18 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001641172-25-009673 | 2 | 19 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Due to EpsilonCat Re / DeltaCat Re Tokenholders | 0 |
| 0001641172-25-009673 | 2 | 21 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 7,442,922 and 6,379,002 shares issued and outstanding) | 0 |
| 0001641172-25-009673 | 2 | 22 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-009673 | 2 | 23 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated Deficit | 0 |
| 0001641172-25-009673 | 2 | 24 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Oxbridge shareholders equity | 0 |
| 0001641172-25-009673 | 2 | 25 | BS | 0 | H | Minority Interest | us-gaap/2024 | Non-controlling interests | 0 |
| 0001641172-25-009673 | 2 | 26 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Total shareholders equity | 0 |
| 0001641172-25-009673 | 2 | 27 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders equity | 0 |
| 0001641172-25-009673 | 3 | 1 | BS | 1 | H | Equity Securities Fv Ni Cost | us-gaap/2024 | Equity securities, cost | 0 |
| 0001641172-25-009673 | 3 | 2 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-009673 | 3 | 3 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-009673 | 3 | 4 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-009673 | 3 | 5 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-009673 | 4 | 2 | IS | 0 | H | Premiums Earned Net | us-gaap/2024 | Net premiums earned | 0 |
| 0001641172-25-009673 | 4 | 3 | IS | 0 | H | Net Investment Income | us-gaap/2024 | Net investment and other income | 0 |
| 0001641172-25-009673 | 4 | 4 | IS | 0 | H | Interest And Gain On Redemption Of Loan | 0001641172-25-009673 | Interest and gain on redemption of loan receivable | 0 |
| 0001641172-25-009673 | 4 | 5 | IS | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Unrealized loss on other investments | 0 |
| 0001641172-25-009673 | 4 | 6 | IS | 0 | H | Realized Investment Gains Losses | us-gaap/2024 | Realized gain on other investments | 0 |
| 0001641172-25-009673 | 4 | 7 | IS | 0 | H | Equity Securities Fv Ni Gain Loss | us-gaap/2024 | Change in fair value of equity securities | 0 |
| 0001641172-25-009673 | 4 | 8 | IS | 0 | H | Revenues | us-gaap/2024 | Total revenue | 0 |
| 0001641172-25-009673 | 4 | 10 | IS | 0 | H | Foreign Reinsurance Transactions Expense Additions To Underwriting Balances | us-gaap/2024 | Policy acquisition costs and underwriting expenses | 0 |
| 0001641172-25-009673 | 4 | 11 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001641172-25-009673 | 4 | 12 | IS | 0 | H | Benefits Losses And Expenses | us-gaap/2024 | Total expenses | 0 |
| 0001641172-25-009673 | 4 | 13 | IS | 0 | H | Loss Income Before Income Attributable To Tokenholders And Noncontrolling Interests | 0001641172-25-009673 | Income (loss) before income attributable to tokenholders and non-controlling interests | 0 |
| 0001641172-25-009673 | 4 | 14 | IS | 0 | H | Income Attributable To Noteholders | 0001641172-25-009673 | Income attributable to tokenholders | 0 |
| 0001641172-25-009673 | 4 | 15 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income attributable to non-controlling interests | 0 |
| 0001641172-25-009673 | 4 | 16 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | Income attributable to non-controlling interests | 1 |
| 0001641172-25-009673 | 4 | 17 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss attributable to ordinary shareholders | 0 |
| 0001641172-25-009673 | 4 | 19 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
| 0001641172-25-009673 | 4 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
| 0001641172-25-009673 | 4 | 22 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
| 0001641172-25-009673 | 4 | 23 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic | 0 |
| 0001641172-25-009673 | 5 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss attributable to ordinary shareholders | 0 |
| 0001641172-25-009673 | 5 | 4 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001641172-25-009673 | 5 | 5 | CF | 0 | H | Realized Investment Gains Losses | us-gaap/2024 | Realized gain on other investments | 1 |
| 0001641172-25-009673 | 5 | 6 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001641172-25-009673 | 5 | 7 | CF | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Change in fair value of other investments | 1 |
| 0001641172-25-009673 | 5 | 8 | CF | 0 | H | Equity Securities Fv Ni Gain Loss | us-gaap/2024 | Change in fair value of equity securities | 1 |
| 0001641172-25-009673 | 5 | 9 | CF | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | Income attributable to non-controlling interests | 0 |
| 0001641172-25-009673 | 5 | 10 | CF | 0 | H | Interest And Gain On Redemption Of Loan Receivable | 0001641172-25-009673 | Interest and gain on redemption of loan receivable | 1 |
| 0001641172-25-009673 | 5 | 11 | CF | 0 | H | Increase Decrease In Operating Right Of Use Asset | 0001641172-25-009673 | Operating right-of-use asset | 1 |
| 0001641172-25-009673 | 5 | 12 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
| 0001641172-25-009673 | 5 | 13 | CF | 0 | H | Increase Decrease In Premiums Receivable | us-gaap/2024 | Premiums receivable | 1 |
| 0001641172-25-009673 | 5 | 14 | CF | 0 | H | Increase Decrease In Deferred Policy Acquisition Costs | us-gaap/2024 | Deferred policy acquisition costs | 1 |
| 0001641172-25-009673 | 5 | 15 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepayment and other assets | 1 |
| 0001641172-25-009673 | 5 | 16 | CF | 0 | H | Increase Decrease In Prepaid Offering Costs | 0001641172-25-009673 | Prepaid Offering Costs | 1 |
| 0001641172-25-009673 | 5 | 17 | CF | 0 | H | Increase Decrease In Unearned Premiums | us-gaap/2024 | Unearned premiums reserve | 0 |
| 0001641172-25-009673 | 5 | 18 | CF | 0 | H | Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | Accounts payable and other liabilities | 0 |
| 0001641172-25-009673 | 5 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash provided by (used in) operating activities | 0 |
| 0001641172-25-009673 | 5 | 21 | CF | 0 | H | Proceeds From Redemption Of Loan Receivable | 0001641172-25-009673 | Proceeds (funding) of loan receivable | 0 |
| 0001641172-25-009673 | 5 | 22 | CF | 0 | H | Proceeds From Sale And Maturity Of Other Investments | us-gaap/2024 | Proceeds from sale of other investments | 0 |
| 0001641172-25-009673 | 5 | 23 | CF | 0 | H | Proceeds From Sale Of Equity Securities Fv Ni | us-gaap/2024 | Proceeds from sale of equity securities | 0 |
| 0001641172-25-009673 | 5 | 24 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0001641172-25-009673 | 5 | 26 | CF | 0 | H | Proceeds From Issuance Of Debt | us-gaap/2024 | EpsilonCat Re / DeltaCat Re Tokenholders | 0 |
| 0001641172-25-009673 | 5 | 27 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Net proceeds from issuance of ordinary shares | 0 |
| 0001641172-25-009673 | 5 | 28 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001641172-25-009673 | 5 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change during the period | 0 |
| 0001641172-25-009673 | 5 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Balance at beginning of period | 0 |
| 0001641172-25-009673 | 5 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Balance at end of period | 0 |
| 0001641172-25-009673 | 5 | 33 | CF | 0 | H | Rightofuse Lease Asset Obtained In Exchange For Operating Lease Liabilities | 0001641172-25-009673 | Right-of-use lease asset obtained in exchange for operating lease liabilities | 0 |
| 0001641172-25-009673 | 5 | 35 | CF | 0 | H | Reclassification To Mezzanine Equity | 0001641172-25-009673 | EpsilonCat Re / DeltaCat Re Tokenholders to Mezzanine Equity | 0 |
| 0001641172-25-009673 | 6 | 9 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009673 | 6 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009673 | 6 | 11 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss attributable to ordinary shareholders | 0 |
| 0001641172-25-009673 | 6 | 12 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2024 | Issuance of restricted stock, net | 0 |
| 0001641172-25-009673 | 6 | 13 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | Issuance of restricted stock, net, shares | 0 |
| 0001641172-25-009673 | 6 | 14 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation Gross | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-009673 | 6 | 15 | EQ | 0 | H | Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | us-gaap/2024 | Income attributable to non-controlling interests | 0 |
| 0001641172-25-009673 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Issuance of shares upon exercise of options | 0 |
| 0001641172-25-009673 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Stock-based compensation, shares | 0 |
| 0001641172-25-009673 | 6 | 18 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of ordinary shares | 0 |
| 0001641172-25-009673 | 6 | 19 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of ordinary shares, shares | 0 |
| 0001641172-25-009673 | 6 | 20 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009673 | 6 | 21 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |